Estrogenic effect of three substituted deoxybenzoins

Deoxybenzoins (1-(2,4-dihydroxyphenyl)-2-(4-hydroxyphenyl)ethanone) are possible precursors or metabolites of isoflavanones which may have xenoestrogenic potential on estrogen receptor (ER). In this study we evaluated three 2'-substituted deoxybenzoin derivatives for their estrogenic effect based upon their ability to affect the proliferation of ERα(+) MCF7 cells, ERβ(+) PC3 cells and Hep2 cells stably transfected and expressing either ERα or ERβ. These compounds designated as CMPD3, CMPD6 and CMPD9 had -COOH, -(CH(2))(4)-CH(3) and -CH(3) substitutions, respectively on the 2'-position of the 2,4-dihydroxyphenyl ring of deoxybenzoin. We found that all three compounds increased the proliferation of ERα(+) MCF7 cells (EC(50)~1-12 μM) and ERα(+) Hep2 cells, while causing apoptosis in ERβ(+) PC3 cells (IC(50)~1-5 μM) and ERβ(+) Hep2 cells. The compounds also up-regulated the expression of estrogen sensitive genes, trefoil factor 1 (TFF1, previously known as pS2) and cathepsin-D (CTSD), in these cells. We performed in vitro ER transcription activation assays using Hep2 cells transiently co-transfected with estrogen response element driven luciferase and either ERα or ERβ vectors to ascertain the mechanism of action of these compounds through the 'classical' genomic pathway of estrogenic activity and to determine their ER subtype selectivity. Molecular docking of the compounds with the Ligand Binding Domain of ERα and ERβ showed similar docking scores (Glidescores of -6.5 to -8.5 kcal/mol) indicating that these compounds were ligands of both ERα and ERβ with similar affinity.

1.12 Tb/s superchannel coherent PM-QPSK InP transmitter photonic integrated circuit (PIC)

In this work, a 10-wavelength, polarization-multiplexed, monolithically integrated InP coherent QPSK transmitter PIC is demonstrated to operate at 112 Gb/sec per wavelength and total chip superchannel bandwidth of 1.12 Tb/s. This demonstration suggests that increasing data capacity to multi-Tb/s per chip is possible and likely in the future.

Descriptor analysis of estrogen receptor β-selective ligands using 2-phenylquinoline, tetrahydrofluorenone and 3-hydroxy 6H-benzo[c]chromen-6-one scaffolds

Estrogen receptor beta (ERβ) selective ligands have attracted much attention recently in the design of anti-cancer drugs that are devoid of the common side effects of estrogen. Structural studies of estrogen receptor alpha (ERα) and β revealed that there were considerable differences in their ligand-binding cavity and in their volume. Hence, the present study has hypothesized that size and shape descriptors can influence the affinity/selectivity of the ligands towards ERβ. To prove the same, quantitative structure-activity relationship (QSAR) analyses were carried out using multiple regression analysis on 2-phenylquinoline, tetrahydrofluorenone and 3-hydroxy-6H-benzo[c]chromen-6-one series. Results indicate that increased lipophilicity, decrease in ellipsoidal volume and width of substituents, presence of halogen atoms was essential for the ligands to have high affinity/selectivity towards ERβ. QSAR models obtained were both internally and externally validated. The study delineates that the size and shape descriptors are best modulators of ERβ affinity/selectivity. Docking studies were performed to support our QSAR results.

Two-trocar laparoscopic cholecystectomy: a reproducible technique

Laparoscopic cholecystectomy is usually performed with a four-trocar technique. From December 1998 to March 1999, 25 of 42 admitted patients underwent a two-trocar laparoscopic cholecystectomy. In our technique, after establishing umbilical carbon dioxide pneumoperitoneum, a 30 degree scope was inserted, and a second 5-mm trocar was positioned below and to the left of the xiphoid process. Then two stitches with nonabsorbable sutures were passed: one at the fundus to pull up the gallbladder, and the second through the neck of the gallbladder to expose the structure of the Calot triangle. Intraoperative cholangiography was performed with a percutaneous catheter in 15 patients. Retrograde cholecystectomy was performed and the gallbladder was extracted through the umbilical port. Scars were closed with glue, and bupivacaine was injected to reduce pain. The technique was feasible in approximately 84% (25 of 30) of patients. The mean operative time was 42 minutes, and the mean hospital stay was 1.6 days. We conclude that this method is similar to four-port laparoscopic cholecystectomy in terms of safety and operation time. This technique seems to be well reproducible and offers better results in terms of postoperative pain, hospital stay without considering better cosmetic results, and cost-effectiveness.

Early experience with laparoscopic radical gastrectomy for advanced gastric cancer

Use of the laparoscopic approach for the management of gastric cancer is still in the developmental phase. The authors present their experience with laparoscopic radical gastrectomy for advanced gastric cancer. Between September 1997 and August 1999, four laparoscopic gastrectomies for gastric carcinoma were performed on two male and two female patients (mean age, 61.5 years). One D2 total radical gastrectomy and three D2 subtotal distal gastrectomies were performed, using a totally laparoscopic approach. Mean operative time was 210 minutes. There were no intraoperative complications. All four patients recovered uneventfully from surgery and began oral feeding on the third postoperative day. Median postoperative stay was 7 days (range, 6-9). All patients were alive 8 months to 3 years after the operation, with no cancer recurrences. This series shows that laparoscopic radical gastrectomy for moderately advanced cancers can produce good results in terms of safety and oncologic adequacy.

Tumor targeting potential of liposomes encapsulating Ga-67 and antibody to Dalton's lymphoma associated antigen (anti-DLAA)

Dalton's lymphoma (solid tumor) was induced in Swiss mice by an 'Air-pouch' technique using ascites cells. A liposomal technique for radioimmunodetection and localization using Ga-67 and antibody has been developed. Dalton's lymphoma associated antigen (DLAA) was isolated and purified by ammonium sulfate fractionation and chromatography. The antibody to this antigen, anti-DLAA, was prepared by immunization of rabbits and purified by CNBr activated chromatography. The specificity of this antibody to the solid tumor antigen was ascertained by agar gel diffusion. Scintiscan studies were carried out using controls and Dalton's lymphoma bearing mice at various time intervals after i.p. administration of 10-20 mu ci of Ga-67, Ga-67 Ga-67 as liposomes and Ga-67 incorporated with antibody to DLAA as liposomes. Extensive studies carried out using liposomes of different sizes and charges revealed that anti-DLAA significantly improved the tumor uptake of Ga-67, thereby facilitating better visualization of the tumor. Negative and neutral liposomes delivered maximum radioactivity at the target tissue, whereas positive liposomes did not cause significant tumor accumulation of 67Ga. Biodistribution studies showed maximum tumor-associated activity that is 15.43% of the injected dose per gram tumor tissue was achieved with Ga-67 anti-DLAA liposomes compared to 6.6% with Ga-67 administered as such. Injection of Ga-67 liposome resulted in minimum tumor-associated activity that is 5.33%, with maximum uptake by liver and spleen. This might be caused by accumulation of liposomes in these organs. Incorporation of anti-DLAA might significantly improve uptake of Ga-67 by target tissue, due to the specificity of the antigen antibody reaction.

Lymphoma-associated antigen (LAA): isolation, characterization and clinical evaluation

Lymphoma-associated antigen (LAA) was isolated from lymph nodes of confirmed Hodgkin's and non-Hodgkin's lymphomas by saline extraction, centrifugation and ammonium sulphate fractionation and then purified by G-200 Sephadex chromatography which revealed its mol.wt at 29 K daltons. By sucrose density-gradient centrifugation the mol.wt of LAA was 43 K daltons. Physicochemical properties of LAA were determined. In polyacrylamide gel LAA separated as a discrete protein with electrophoretic mobility of alpha-globulin at pH 8.6. The pI was 5.04 and sedimentation coefficient between 3S-4S. Xenogeneic antiserum was raised in rabbits and purified by cross adsorption and affinity chromatography. By immunochemical methods, LAA was detected in the sera and body fluids of most lymphoma patients and was absent from normal individuals and patients with other types of cancer. A radioimmunoassay procedure was developed and preliminary studies revealed that the lymphoma sera at 1:5 and 1:10 dilution inhibited the binding of labelled LAA by antibody, whereas the sera of normals and controls exhibited no such inhibition. The sensitivity of this assay was 22 ng ml-1. The serum LAA levels were in the range of 187-1500 ng ml-1. These results were also confirmed by the indirect inhibition assay using conjugated peroxidase. Serial determination of serum LAA by RIA indicated a positive correlation with the course of disease.